UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

       Date of Report (Date of earliest event reported): OCTOBER 30, 2006

                              Alfacell Corporation
             (Exact name of registrant as specified in its charter)

                                     0-11088
                            (Commission File Number)

             DELAWARE                                 22-2369085
   (State or other jurisdiction of      (I.R.S. Employer Identification No.)
    incorporation)

               225 BELLEVILLE AVENUE, BLOOMFIELD, NEW JERSEY 07003
             (Address of principal executive offices, with zip code)

                                 (973) 748-8082
              (Registrant's telephone number, including area code)

                                 NOT APPLICABLE
          (Former name or former address, if changed since last report)


     Check the  appropriate  box below if the Form 8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions (SEE General Instruction A.2. below):

     [ ]  Written communications pursuant to Rule 425 under the Securities Act
          (17 CFR 230.425)

     [ ]  Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act
          (17 CFR 240.14a-12)

     [ ]  Pre-commencement  communications pursuant to Rule 14d-2(b) under the
          Exchange Act (17 CFR 240.14d-2(b))

     [ ]  Pre-commencement  communications pursuant to Rule 13e-4(c) under the
          Exchange Act (17 CFR 240.13e-4(c))



ITEM 2.02   RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

     On October 30, 2006,  Alfacell  Corporation (the "Company")  issued a press
release reporting  financial  results and key Company  highlights for the fourth
quarter and the 2006 fiscal  year,  ending  July 31,  2006.  A copy of the press
release is filed as Exhibit 99.1 hereto and incorporated herein by reference.

     The  information  in this  Item  2.02,  including  Exhibit  99.1,  is being
furnished  and shall not be deemed to be "filed"  for  purposes of Section 18 of
the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to
the  liability  of that  Section,  nor shall  such  information  be deemed to be
incorporated  by reference  into any  registration  statement or other  document
filed under the Securities Act of 1933 or the Exchange Act,  except as otherwise
stated in that filing.


ITEM 8.01   OTHER EVENTS.

     On October 30, 2006,  Alfacell  Corporation (the "Company")  issued a press
release reporting  financial  results and key Company  highlights for the fourth
quarter and the 2006 fiscal  year,  ending  July 31,  2006.  A copy of the press
release is filed as Exhibit 99.1 hereto and incorporated herein by reference.

ITEM 9.01   FINANCIAL STATEMENTS AND EXHIBITS.

(c)      Exhibits.

99.1     Press release of Alfacell Corporation dated October 30, 2006.

                                      -2-



                                   SIGNATURES



Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


                                          ALFACELL CORPORATION



Date:  October 30, 2006                   By:    /s/ Robert D. Love
                                              ------------------------------
                                                 Robert D. Love
                                                 Chief Financial Officer


                                      -3-